How has been the historical performance of Biofil Chemicals?

Answer:The historical performance of Biofil Chemicals shows fluctuations in key financial metrics over the years, with notable changes in net sales, profits, and overall financial health.

Breakdown:
Biofil Chemicals reported net sales of 33.40 Cr in March 2025, a decrease from 40.04 Cr in March 2024 but an increase from 30.04 Cr in March 2023. The total operating income followed a similar trend, with a peak of 40.04 Cr in March 2024 and a low of 22.38 Cr in March 2022. The company's total expenditure, excluding depreciation, was 32.55 Cr in March 2025, down from 39.22 Cr in March 2024. Operating profit (PBDIT) was 1.16 Cr in March 2025, slightly lower than 1.31 Cr in March 2024, while profit before tax decreased to 0.74 Cr from 0.87 Cr in the previous year. The profit after tax for March 2025 was 0.56 Cr, consistent with the figure from March 2023 but lower than 0.71 Cr in March 2024. The company's total assets rose to 47.08 Cr in March 2024 from 31.41 Cr in March 2023, reflecting growth in current assets, particularly in sundry debtors, which increased to 33.03 Cr in March 2024. Total liabilities also increased to 47.08 Cr in March 2024, driven by higher trade payables. Cash flow from operating activities showed a significant improvement, reaching 2.00 Cr in March 2024, compared to 0.00 Cr in March 2023, indicating a positive shift in cash management.